Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 8, 2025 (Expiration)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports research on the biological and molecular mechanisms underlying bladder cancer initiation, progression, and recurrence.
Key Information: Clinical trial proposals are optional; projects focused on therapeutic trials or MIBC clinical outcomes are not responsive.